Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Haleezy
- Development stage
- Unknown
- Lead developer
- Charak
- Administration
- Oral
01
Overview
Haleezy is a proprietary Ayurvedic polyherbal formulation developed by Charak Pharma to support respiratory health. It is formulated with natural bronchodilator, anti-inflammatory, and anti-allergic herbal ingredients, including Adhatoda vasica (Vasa), Solanum xanthocarpum (Kantakari), Curcuma longa (Haridra), and Ocimum sanctum (Tulsi). Haleezy is indicated for the management of bronchial asthma, chronic bronchitis, and as an adjuvant therapy in chronic obstructive pulmonary disease (COPD). It helps to promote airway relaxation, reduce mucus secretion, and alleviate bronchospasms without the risk of tremors associated with some synthetic bronchodilators.
- Brand names
- Haleezy
Beyond the preview
Go deeper on Haleezy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Haleezy.